21 N.C. Admin. Code 61 .0103 - DEFINITIONS
The definitions of terms contained in G.S. 90-648 shall apply to the rules in this Chapter. In addition, the following definitions shall apply to the rules in this Chapter:
(1) "Assessment" means a
clinical evaluation of an individual patient by a Respiratory Care Practitioner
(RCP) or other licensed health care provider within their scope of practice to
determine the ability and efficacy of a respiratory care procedure, protocol,
or treatment, including an assessment of the suitability and efficacy of
equipment for an individual patient if equipment is to be used in the procedure
or treatment.
(2) "Respiratory
care" means the health care discipline that specializes in the promotion of
optimum cardiopulmonary function and health and wellness using scientific
principles to identify, treat and prevent acute or chronic dysfunction of the
cardiopulmonary system pursuant to
G.S.
90-648(11) that is taught in
accredited educational programs pursuant to
G.S.
90-653(3) or in approved
continuing education programs pursuant to the rules of this Chapter within the
guidelines established by the American Association for Respiratory Care,
incorporated by reference including subsequent amendments and editions,
pursuant to
G.S.
90-648(10)(f). Copies of the
guidelines may be found at
https://www.aarc.org/resources/clinical-resources/clinical-practice-guidelines/
at no cost.
(3) "The practice of
respiratory care" means the performance of assessments and diagnostic tests,
and implementation of treatment procedures and protocols related to the
cardiopulmonary system pursuant to
G.S.
90-648(10) and the
activities defined by the American Association of Respiratory Care clinical
guidelines, incorporated by reference including subsequent amendments and
editions, pursuant to
G.S.
90-648(10)(f). Copies of the
guidelines may be found at
https://www.aarc.org/resources/clinical-resources/clinical-practice-guidelines/at
no cost.
(4) "Medical gases" mean
those inhaled gases used in the treatment of cardiopulmonary disease.
(5) "Humidity" means adding heat or moisture
to an inhaled medical gas.
(6)
"Aerosols" mean the suspension of particles dispersed in air or gas to deliver
medication or humidity to the airways.
(7) "Pharmacologic agent" means a medication
or medical gas delivered during a respiratory care procedure for the treatment
of cardiopulmonary disease.
(8)
"Hyperbaric oxygen therapy" means inhalation of high concentrations of oxygen
at increased levels of atmospheric pressures within a total body chamber for
the treatment of cardiopulmonary disorders or wounds.
(9) "Mechanical or physiological ventilatory
support" means the provision of an apparatus to support gas exchange associated
with cardiopulmonary dysfunction.
(10) "Hemodynamic monitoring" means a
procedure required to monitor blood pressure invasively or
noninvasively.
(11) "Diagnostic
testing" means a procedure for assessing the function of the cardiopulmonary
system and diagnosing cardiopulmonary disease or sleep related
disorders.
(12) "Therapeutic
application" means utilizing evidenced-based protocols, procedures, treatments,
or modalities defined in this Chapter to maintain cardiopulmonary health or
treat cardiopulmonary disease.
(13)
"Active status" means a license issued to an individual after meeting the
requirements of
G.S.
90-653.
(14) "Endorsement" means a license issued by
the Board recognizing the person named on the certificate as having met the
requirements to perform respiratory care procedures pursuant to the rules of
this Chapter.
Notes
Temporary Adoption Eff. October 15, 2001;
Eff. August 1, 2002;
Amended Eff. September 1, 2010; January 1, 2007; March 1, 2006.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.